相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: A systematic review and meta-analysis
Qianqian Zhu et al.
ANTIVIRAL RESEARCH (2013)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b
Masanori Atsukawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Edward J. Gane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pitavastatin enhances antiviral efficacy of standard pegylated interferon plus ribavirin in patients with chronic hepatitis C: A prospective randomized pilot study
Masahiko Shimada et al.
JOURNAL OF HEPATOLOGY (2012)
An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin
C. Kondo et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C
Gowtham A. Rao et al.
GASTROENTEROLOGY (2011)
Statin, Beyond Hyperlipidemia toward a Novel Agent for Hepatitis C
Mahmoud A. Khattab et al.
HEPATITIS MONTHLY (2011)
Hepatitis C virus resistance to protease inhibitors
Philippe Halfon et al.
JOURNAL OF HEPATOLOGY (2011)
Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C
K. Patel et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Statins Potentiate the In Vitro Anti-Hepatitis C Virus Activity of Selective Hepatitis C Virus Inhibitors and Delay or Prevent Resistance Development
Leen Delang et al.
HEPATOLOGY (2009)
An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads
Hitomi Sezaki et al.
INTERVIROLOGY (2009)
Fluvastatin inhibits hepatitis C replication in humans
Ted Bader et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: A pilot clinical trial
Jacqueline G. O'Leary et al.
HEPATOLOGY (2007)
Different anti-HCV profiles of statins and their potential for combination therapy with interferon
Masanori Ikeda et al.
HEPATOLOGY (2006)
Identification of FBL2 as a geranylgeranylated required for hepatitis C cellular protein virus RNA replication
CF Wang et al.
MOLECULAR CELL (2005)
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids
SB Kapadia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
